
Triq Pharmaceuticals Private Limited
Founded in 2024 and headquartered in Telangana, India.
Founded in 2024 and headquartered in Telangana, India.
Triq Pharmaceuticals Private Limited (TPPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 September 2024 ( seven months 22 days old ). Its registered office is in Rangareddy, Telangana, India.
The Company is engaged in the Paper Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Subrahmanyam Gonupalli and Nikil Dudi serve as directors at the Company.
Rangareddy, Telangana, India
+91-XXXXXXXXXX
U21000TS2024PTC189150
189150
Private Limited Indian Non-Government Company
04 Sep 2024
-
-
Unlisted
Roc Hyderabad
Name | Designation | Appointment Date | Status |
---|---|---|---|
Subrahmanyam Gonupalli ![]() | Director | 04-Sep-2024 | Current |
Nikil Dudi ![]() | Director | 04-Sep-2024 | Current |
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Triq Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Subrahmanyam Gonupalli is a mutual person
Nikil Dudi is a mutual person
Nikil Dudi is a mutual person
Nikil Dudi is a mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Triq Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Triq Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Triq Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Subrahmanyam Gonupalli was appointed as a Director was appointed as a Director on 04 Sep 2024 & has been associated with this company since 7 months 22 days .
Nikil Dudi was appointed as a Director was appointed as a Director on 04 Sep 2024 & has been associated with this company since 7 months 22 days .
Triq Pharmaceuticals Private Limited was registered on 04 Sep 2024 with Roc Hyderabad & aged 7 months 22 days as per MCA records.
Triq Pharmaceuticals Private Limited was incorporated on 04 Sep 2024.
The authorized share capital of Triq Pharmaceuticals Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.
Currently 2 directors are associated with Triq Pharmaceuticals Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Triq Pharmaceuticals Private Limited is 322 G-Block Gulmohar Garden Shakthi Sai Nagar, India, Uppal, Telangana, 500076.
The corporate identification number (CIN) of Triq Pharmaceuticals Private Limited is U21000TS2024PTC189150 and the company number is 189150 as per Ministry of Corporate Affairs (MCA).
Search company & director profiles for free and gain access to critical business data.